| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TherapeuticsMD, Inc. | Prin. Fin. and Acctg. Officer | Common Stock | 61,853 | $138,489 | $2.24 | 12 Apr 2023 | Direct |
| TherapeuticsMD, Inc. | Prin. Fin. and Acctg. Officer | Restricted Stock Units | 0 | $3.64 | 12 Apr 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TXMD | TherapeuticsMD, Inc. | 12 Apr 2023 | 2 | $0 | 4 | Prin. Fin. and Acctg. Officer | 14 Apr 2023, 19:17 |
| TXMD | TherapeuticsMD, Inc. | 21 Feb 2023 | 1 | $0 | 4 | Prin. Fin. and Acctg. Officer | 23 Feb 2023, 16:11 |
| TXMD | TherapeuticsMD, Inc. | 26 Jan 2023 | 8 | -$8,621 | 4 | Prin. Fin. and Acctg. Officer | 30 Jan 2023, 17:40 |
| TXMD | TherapeuticsMD, Inc. | 23 Jan 2023 | 10 | -$6,988 | 4 | Prin. Fin. and Acctg. Officer | 25 Jan 2023, 16:50 |
| TXMD | TherapeuticsMD, Inc. | 06 Dec 2022 | 9 | -$4,345 | 4 | Interim CFO/CAO/VP of Finance | 09 Dec 2022, 18:37 |
| TXMD | TherapeuticsMD, Inc. | 31 Mar 2022 | 1 | $0 | 4 | CAO and VP of Finance | 31 Mar 2022, 17:15 |
| TXMD | TherapeuticsMD, Inc. | 23 Mar 2022 | 1 | $0 | 4 | CAO and VP of Finance | 28 Mar 2022, 07:00 |
| TXMD | TherapeuticsMD, Inc. | 30 Nov 2021 | 3 | -$15,947 | 4 | CAO and VP of Finance | 02 Dec 2021, 05:30 |
| TXMD | TherapeuticsMD, Inc. | 29 Sep 2021 | 5 | $0 | 4 | CAO and VP of Finance | 01 Oct 2021, 17:00 |
| TXMD | TherapeuticsMD, Inc. | 01 Jul 2021 | 2 | $0 | 4 | CAO and VP Finance | 02 Jul 2021, 17:42 |
| TXMD | TherapeuticsMD, Inc. | 10 May 2021 | 3 | -$5,036 | 4 | CAO and VP Finance | 12 May 2021, 20:44 |